These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 7833122)

  • 21. [Is proton beam therapy the future of radiotherapy? Part I: clinical aspects].
    Bouyon-Monteau A; Habrand JL; Datchary J; Alapetite C; Bolle S; Dendale R; Feuvret L; Helfre S; Calugaru V; Cosset JM; Bey P
    Cancer Radiother; 2010 Dec; 14(8):727-38. PubMed ID: 20427218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Basics of particle therapy: introduction to hadrons.
    Welsh JS
    Am J Clin Oncol; 2008 Oct; 31(5):493-5. PubMed ID: 18838888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shaping of photon beams from electron linear accelerators in radiation therapy.
    Izewska J
    Med Phys; 1993; 20(1):171-7. PubMed ID: 8455496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Energy of proton accelerator necessary for treatment of choroidal melanomas.
    Goitein M; Gentry R; Koehler AM
    Int J Radiat Oncol Biol Phys; 1983 Feb; 9(2):259-60. PubMed ID: 6300000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential advantages of protons over conventional radiation beams for paraspinal tumours.
    Isacsson U; Hagberg H; Johansson KA; Montelius A; Jung B; Glimelius B
    Radiother Oncol; 1997 Oct; 45(1):63-70. PubMed ID: 9364633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical experience with particle therapy in adults.
    Schulz-Ertner D
    Cancer J; 2009; 15(4):306-11. PubMed ID: 19672147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initial results with one-year minimum follow-up of the first 146 patients with a uveal melanoma treated with protons at CPO (Orsay).
    Schlienger P; Habrand JL; Schwartz L; Desjardins L; d'Hermies F; Frau E; Mazal A; Delacroix S; Nauraye C; Ferrand R; Louis M
    Bull Cancer Radiother; 1996; 83 Suppl():212s-4s. PubMed ID: 8949782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conservative treatment of uveal melanoma: local recurrence after proton beam therapy.
    Munzenrider JE; Verhey LJ; Gragoudas ES; Seddon JM; Urie M; Gentry R; Birnbaum S; Ruotolo DM; Crowell C; McManus P
    Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):493-8. PubMed ID: 2550395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical applications of proton therapy.
    Habrand JL; Schlienger P; Schwartz L; Pontvert D; Lenir-Cohen-Solal C; Helfre S; Mammar H; Haie-Meder C; Ferrand R; Mazal A
    Bull Cancer Radiother; 1996; 83 Suppl():207s-11s. PubMed ID: 8949781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Outcomes of Proton Radiotherapy for Uveal Melanoma.
    Verma V; Mehta MP
    Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):e17-27. PubMed ID: 26915706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The case for particle therapy.
    Jones B
    Br J Radiol; 2006 Jan; 79(937):24-31. PubMed ID: 16421401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton beam therapy for the treatment of uveal melanoma in Scotland.
    Macdonald EC; Cauchi P; Kemp EG
    Br J Ophthalmol; 2011 Dec; 95(12):1691-5. PubMed ID: 21216794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Proton beam radiotherapy of uveal melanoma--preliminary results].
    Romanowska-Dixon B; Pogrzebielski A; Bogdali A; Markiewicz A; Swakoń J; Olko P; Jezabek M; Sas-Korczyńska B; Pluta E
    Klin Oczna; 2012; 114(3):173-9. PubMed ID: 23373396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
    Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
    Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of clinical experience with ion beam radiotherapy.
    Jensen AD; Münter MW; Debus J
    Br J Radiol; 2011 Dec; 84 Spec No 1(Spec Iss 1):S35-47. PubMed ID: 21427183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton therapy at Harvard.
    Munzenrider JE; Austin-Seymour M; Blitzer PJ; Gentry R; Goitein M; Gragoudas ES; Johnson K; Koehler AM; McNulty P; Moulton G
    Strahlentherapie; 1985 Dec; 161(12):756-63. PubMed ID: 3001976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Proton radiotherapy].
    Okumura T; Tsuji H; Tsujii H
    Gan To Kagaku Ryoho; 1993 Nov; 20(14):2149-55. PubMed ID: 8239679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization of physical dose distributions with hadron beams: comparing photon IMRT with IMPT.
    Oelfke U; Bortfeld T
    Technol Cancer Res Treat; 2003 Oct; 2(5):401-12. PubMed ID: 14529305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Revisiting the ultra-high dose rate effect: implications for charged particle radiotherapy using protons and light ions.
    Wilson P; Jones B; Yokoi T; Hill M; Vojnovic B
    Br J Radiol; 2012 Oct; 85(1018):e933-9. PubMed ID: 22496068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton beam irradiation of uveal melanomas at Paul Scherrer Institute (former SIN).
    Zografos L; Perret C; Egger E; Gailloud C; Greiner R
    Strahlenther Onkol; 1990 Jan; 166(1):114. PubMed ID: 2154044
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.